Chen-Yu Hu

568 total citations
19 papers, 371 citations indexed

About

Chen-Yu Hu is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Chen-Yu Hu has authored 19 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Cancer Research. Recurrent topics in Chen-Yu Hu's work include Ferroptosis and cancer prognosis (3 papers), Hepatitis B Virus Studies (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Chen-Yu Hu is often cited by papers focused on Ferroptosis and cancer prognosis (3 papers), Hepatitis B Virus Studies (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Chen-Yu Hu collaborates with scholars based in China, United States and Ethiopia. Chen-Yu Hu's co-authors include Xiaofeng Liu, Chunfeng Zhang, Xiaojuan Du, Baocai Xing, Min Lu, Hangping Yao, Tian-Hao Weng, Xiaoyan Sun, Lijun Wang and Yang Jiang and has published in prestigious journals such as Blood, Frontiers in Microbiology and Medicine.

In The Last Decade

Chen-Yu Hu

18 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chen-Yu Hu China 12 214 126 85 55 43 19 371
Xiaolong Liang China 12 179 0.8× 144 1.1× 99 1.2× 26 0.5× 21 0.5× 36 381
Esther Redín Spain 12 175 0.8× 111 0.9× 128 1.5× 72 1.3× 17 0.4× 19 337
Arpita Singha Roy Bangladesh 7 205 1.0× 56 0.4× 86 1.0× 51 0.9× 71 1.7× 15 356
Chaoyi Yuan China 7 138 0.6× 63 0.5× 69 0.8× 38 0.7× 23 0.5× 12 247
Pingguo Liu China 13 194 0.9× 80 0.6× 98 1.2× 34 0.6× 36 0.8× 30 357
Jie-Fu Huang China 7 157 0.7× 81 0.6× 76 0.9× 92 1.7× 68 1.6× 10 411
Yinghan Su China 9 204 1.0× 136 1.1× 71 0.8× 28 0.5× 42 1.0× 11 305
Xi Ai China 10 163 0.8× 80 0.6× 90 1.1× 24 0.4× 101 2.3× 24 361
Jingbo Kang China 10 124 0.6× 44 0.3× 84 1.0× 44 0.8× 62 1.4× 21 314
Rayna Venook United States 5 218 1.0× 59 0.5× 74 0.9× 79 1.4× 29 0.7× 6 348

Countries citing papers authored by Chen-Yu Hu

Since Specialization
Citations

This map shows the geographic impact of Chen-Yu Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen-Yu Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen-Yu Hu more than expected).

Fields of papers citing papers by Chen-Yu Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen-Yu Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen-Yu Hu. The network helps show where Chen-Yu Hu may publish in the future.

Co-authorship network of co-authors of Chen-Yu Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Chen-Yu Hu. A scholar is included among the top collaborators of Chen-Yu Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen-Yu Hu. Chen-Yu Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hu, Chen-Yu, Chunfeng Zhang, Ming Liu, et al.. (2024). LncRNA-HMG incites colorectal cancer cells to chemoresistance via repressing p53-mediated ferroptosis. Redox Biology. 77. 103362–103362. 12 indexed citations
2.
Wang, Ruizhen, Xue Bai, Jingzhou Wang, et al.. (2024). Integrated analysis reveals that miR-548ab promotes the development of obesity and T2DM. Journal of genetics and genomics. 52(2). 231–244.
3.
Hu, Chen-Yu, Xiaoyan Sun, Yang Hu, et al.. (2023). Activation of ACLY by SEC63 deploys metabolic reprogramming to facilitate hepatocellular carcinoma metastasis upon endoplasmic reticulum stress. Journal of Experimental & Clinical Cancer Research. 42(1). 108–108. 35 indexed citations
4.
Zhang, Chunfeng, Yang Yang, Kun Wang, et al.. (2022). The Systematic Analyses of RING Finger Gene Signature for Predicting the Prognosis of Patients with Hepatocellular Carcinoma. Journal of Oncology. 2022. 1–17. 12 indexed citations
5.
Zhang, Chunfeng, Chen-Yu Hu, Kun Wang, et al.. (2021). The Integrative Analysis of Thrombospondin Family Genes in Pan-Cancer Reveals that THBS2 Facilitates Gastrointestinal Cancer Metastasis. Journal of Oncology. 2021. 1–19. 19 indexed citations
6.
Liu, Xiaofeng, Xiaoyan Sun, Yang Jiang, et al.. (2021). Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway. Journal of Experimental & Clinical Cancer Research. 40(1). 132–132. 138 indexed citations
7.
Weng, Tian-Hao, Minya Yao, Chen-Yu Hu, et al.. (2020). RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer. Cancer Research and Treatment. 52(3). 973–986. 21 indexed citations
8.
9.
Yao, Hangping, Liang Feng, Linghui Chen, et al.. (2019). Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy. Journal for ImmunoTherapy of Cancer. 7(1). 75–75. 19 indexed citations
10.
Hu, Chen-Yu, et al.. (2019). Immunological microenvironment alterations in follicles of women with proven severe endometriosis undergoing in vitro fertilization. Molecular Biology Reports. 46(5). 4675–4684. 7 indexed citations
11.
Yao, Hangping, Tian-Hao Weng, Chen-Yu Hu, et al.. (2018). RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE. Molecular Cancer Therapeutics. 17(12). 2654–2664. 23 indexed citations
12.
Weng, Tian-Hao, Chen-Yu Hu, Zhigang Wu, et al.. (2018). Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus trVLPs and Interact With trVLP Elements. Frontiers in Microbiology. 9. 2724–2724. 3 indexed citations
13.
Weng, Tian-Hao, Ling Shen, Xiaoxin Wu, et al.. (2018). Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40. Cellular Physiology and Biochemistry. 50(3). 1055–1067. 4 indexed citations
14.
Wu, Xiaoxin, Xilong Deng, Wei Yao, et al.. (2018). The Protective Effects of the A/ZJU01/ PR8/2013 Split H7N9 Avian Influenza Vaccine Against Highly Pathogenic H7N9 in BALB/c Mice. Cellular Physiology and Biochemistry. 46(2). 633–643. 9 indexed citations
15.
Yao, Hangping, Liang Feng, Tian-Hao Weng, et al.. (2018). Preclinical Efficacy of Anti-RON Antibody–Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine Kinase. Molecular Pharmaceutics. 15(8). 3260–3271. 20 indexed citations
16.
Gao, Hainv, Yunfeng Xiao, Tian-Hao Weng, et al.. (2018). Bioinformatics Analysis on Potential Anti-Viral Targets Against Spike Protein of MERS-CoV. 55. 67–71. 2 indexed citations
17.
Qian, Yun, Limin Feng, Tian-Hao Weng, et al.. (2017). MicroRNA Expression Profiling of Pancreatic Cancer Cell Line L3.6p1 Following B7-H4 Knockdown. Cellular Physiology and Biochemistry. 44(2). 494–504. 18 indexed citations
18.
Wu, Xiaoxin, Yeping Wang, Tian-Hao Weng, et al.. (2017). Preparation of immunochromatographic strips for rapid detection of early secreted protein ESAT-6 and culture filtrate protein CFP-10 from Mycobacterium tuberculosis. Medicine. 96(51). e9350–e9350. 13 indexed citations
19.
Kornblau, Steven M., Chen-Yu Hu, Yi Hua Qiu, et al.. (2013). Hippo Pathway (HP) Activity In Acute Myelogenous Leukemia (AML): Different Prognostic Implications Of TAZ versus YAP Inactivation By Phosphorylation. Blood. 122(21). 1337–1337. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026